Serial Number | 79151519 |
Word Mark | PANPHARMA |
Filing Date | Monday, May 19, 2014 |
Status | 709 - CANCELLED - SECTION 71 |
Status Date | Friday, February 4, 2022 |
Registration Number | 4774728 |
Registration Date | Tuesday, July 21, 2015 |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, May 5, 2015 |
Goods and Services | Pharmaceutical preparations for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; pharmaceutical preparations for smoking cessation, pharmaceutical sedatives, tranquilizers, depuratives for the body; vitamin, mineral supplements and vaccines for use on domestic animals and livestock for veterinary purposes; dietetic foods, namely, crackers, cakes, soup, meal replacement bars, fruit and vegetable granules adapted for medical use; pesticides, namely, preparations for destroying vermin within the province of the pharmaceutical sector |
Pseudo Mark | PAN PHARMA |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, February 4, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | PANPHARMA, Société anonyme |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | F-35133 LUITRE FR |
Party Name | PANPHARMA, Société anonyme |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | F-35133 LUITRE FR |
Party Name | PANPHARMA, Société anonyme |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | F-35133 LUITRE FR |
Event Date | Event Description |
Friday, November 17, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
Sunday, November 13, 2022 | TOTAL INVALIDATION PROCESSED BY THE IB |
Friday, October 14, 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
Friday, October 14, 2022 | INVALIDATION PROCESSED |
Tuesday, October 4, 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
Friday, February 4, 2022 | CANCELLED SECTION 71 |
Thursday, December 2, 2021 | INTERNATIONAL REGISTRATION RENEWED |
Saturday, February 27, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
Tuesday, July 21, 2020 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Friday, February 5, 2016 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Thursday, December 10, 2015 | GENERIC MADRID TRANSACTION SENT TO IB |
Thursday, December 10, 2015 | GENERIC MADRID TRANSACTION CREATED |
Wednesday, October 21, 2015 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, July 21, 2015 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, May 5, 2015 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, May 5, 2015 | PUBLISHED FOR OPPOSITION |
Saturday, May 2, 2015 | NOTIFICATION PROCESSED BY IB |
Wednesday, April 15, 2015 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, April 15, 2015 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, April 15, 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Saturday, March 28, 2015 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Monday, March 23, 2015 | ASSIGNED TO LIE |
Wednesday, March 4, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, March 3, 2015 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, March 3, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, March 3, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, March 3, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, September 25, 2014 | REFUSAL PROCESSED BY IB |
Saturday, September 6, 2014 | APPLICATION FILING RECEIPT MAILED |
Friday, September 5, 2014 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Friday, September 5, 2014 | REFUSAL PROCESSED BY MPU |
Friday, September 5, 2014 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, September 4, 2014 | NON-FINAL ACTION WRITTEN |
Wednesday, September 3, 2014 | ASSIGNED TO EXAMINER |
Tuesday, September 2, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, August 28, 2014 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |